We had tested this theory on research models, but this is the first time anyone has shown the therapy's effectiveness in people," said Michael Ihnat, Ph.D., principal investigator and a pharmacologist at the OU College of Medicine Department of Cell Biology.
The team is now working to determine how antioxidants work at the molecular level to halt the destructive chain reaction set in motion by high blood sugar levels.
Reference:
Ceriello et al. Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. Journal of Clinical Endocrinology & Metabolism, 2009.
Weblink:
No comments:
Post a Comment